Exhibition Review | 8th Tianjin Nucleic Acid Medical Conference
Release Date:2024-09-30
The 8th China (Tianjin) Nucleic Acid Medicine Conference successfully concluded in Tianjin on September 25-26, 2024! This conference was of great significance. Academicians and and experts from 6 fields, including the industrial sector, were invited to participate, aiming to build a cooperation and exchange platform, explore new opportunities for innovative development in China's nucleic acid medicine industry, and strive to build an industrial ecosystem. ZhongSheng Bio-Tech was honored to attend this conference as an exhibitor and sponsor, and to discuss the latest trends in nucleic acid technology and raw material markets with professional experts in the industry.
Recent News
On March 15, 2025, the three-day 2025 E-Trade Bio-industry Conference (BIOCHINA) successfully concluded at Suzhou International Expo Center. This conference, themed "Innovation Without Borders, Collaborative Coexistence," gathered 850 top global speakers and 30,000 professional attendees, covering 50,000㎡ of exhibition space, comprehensively showcasing cutting-edge technologies and industrial potential in the biomedical field. As a leader in the nucleic acid raw material sector, Allbiosyn Bio showcased its core product matrix at the exhibition, to jointly explore the future of nucleic acid drug industrialization with global partners.
Imetelstat is the world's first approved telomerase inhibitor drug, developed by Geron Corporation in the United States, and approved by the FDA on June 6, 2024 (trade name Rytelo®), for the treatment of adult patients with lower-risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia.
Allbiosyn (Shanghai) Biotechnology Co., Ltd. cordially invites you to visit Booth 66 in Hall SD3 at BIOCHINA2025, to jointly explore the future landscape of nucleic acid technology!
2025 New Spring, Allbiosyn Biotechnology embarks on a new journey with you!
As Chinese New Year arrives, auspicious energy descends! Aobai Xin (Shanghai) Biotechnology Co., Ltd., along with all its staff, extends New Year greetings to you!
Christmas and New Year's Day, continuous stock.
As Christmas and New Year's Day approach, Aobaixin sends you and your team the most sincere holiday greetings! May this joyous and harmonious holiday bring you abundant warmth and happiness.
The highly anticipated TIDES Europe 2024, a premier event in the European oligonucleotide and peptide fields, will take place from November 12-14, 2024, in Hamburg, Germany. This year's conference will feature discussions on themes including oligonucleotide CMC, oligonucleotide discovery/preclinical/clinical research, peptide CMC, peptide discovery/preclinical/clinical research, mRNA therapy, and genome editing.
Wish to receive more updates from Allbiosyn
Stay up-to-date with the latest product releases, technology trends, and upcoming events.
- All
- Product Management
- News Information
- Introduction Content
- Enterprise Outlets
- FAQ
- Corporate Video
- Corporate Album
Phone:+8618666985712
Email:info@allbiosyn.com
WeChat ID: 18666985712
Address: Building 1, 883-885 Pinggang Road, Lingang New Area, Shanghai
Copyright © 2025 Allbiosyn (Shanghai) Biotechnology Co., Ltd. All Rights Reserved.